Replies to post #1965 on Insmed Inc (INSM)

[rstor1]

Slacker,

THe PR is not directed at the insurance/medical community nor at the target patient population.

It is directed at the investor community. They need to find a USP for Increlex that potential buyers of the coming financing will accept, and "lower price" is the one thing that they've decided to hang their hats on.

They can raise up to 75 mil with Kingdbridge, per the financing agreement:

http://www.mpmcapital.com/flash/news/051014.pdf

My guess is that they are either getting ready to do another offering (although I have not checked to see if any of the shelf is left) or they are getting ready to draw down some of the kingsbrige money, and they want to pump the sp beforehand.

Regards,
Bob

[y3maxx]

>>They have to know that branding Increlex as the discount option could have a negative impact on sales,<<

Perhaps they have no sales and have therefore nothing to lose.

Perhaps they want to initiate a pricing war with INSM.